Patrick Stragier

Director/Board Member at

Dendrogenix SA

Health Technology

Finance

Process Industries

Profile

Patrick Stragier is the founder of MaSTherCell SA, which was founded in 2010.
He held the title of COO & CBO from 2010 to 2015.
Currently, he is a Director at Dendrogenix SA and an Investment Manager at Noshaq SA, where he started in 2021.
Previously, he worked as a Director of Clinical Manufacturing at Genzyme Flanders BVBA from 2000 to 2002, as Managing Director at Lonza Verviers from 2002 to 2009, as Cell Therapy Platform Director at BioWin ASBL from 2009 to 2010, as Vice President-Operations at PROMETHERA Biosciences SA from 2015 to 2017, as General Manager at Catalent Belgium SA from 2020 to 2021, and as Chief Transformation Officer at Cell Matters SA from 2021 to 2022.

Patrick Stragier active positions

Companies	Position	Start
Noshaq SA Noshaq SA Investment ManagersFinance Noshaq SA is an active manager which invests in companies located in Belgium with a focus on the Liège area. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed stage, early stage, later stage and growth stage.	Private Equity Investor	2021-10-31
Dendrogenix SA Dendrogenix SA Pharmaceuticals: MajorHealth Technology Develops molecules and dendrogenins to treat hormone-dependent breast cancer	Director/Board Member	-

All active positions of Patrick Stragier

Former positions of Patrick Stragier

Companies	Position	End
Cell Matters SA Cell Matters SA BiotechnologyHealth Technology Engages in cryo-processing and cryopreservation solutions	Corporate Officer/Principal	2022-09-30
Catalent Belgium SA Catalent Belgium SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals	Corporate Officer/Principal	2021-07-31
PROMETHERA Biosciences SA PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases	Corporate Officer/Principal	2017-09-30
Catalent Gosselies NV Catalent Gosselies NV BiotechnologyHealth Technology Provides cell therapy manufacturing services	Founder	2015-04-30
BioWin ASBL BioWin ASBL Miscellaneous Commercial ServicesCommercial Services Provides support for research and development of biomarkers	Corporate Officer/Principal	2010-06-30

See the detail of Patrick Stragier's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Patrick Stragier's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	9
Noshaq SA Noshaq SA Investment ManagersFinance Noshaq SA is an active manager which invests in companies located in Belgium with a focus on the Liège area. The firm targets companies operating across a broad range of sectors and industries. It provides financing for seed stage, early stage, later stage and growth stage.	Finance
PROMETHERA Biosciences SA PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases	Health Technology
Catalent Belgium SA Catalent Belgium SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals	Health Technology
Genzyme Flanders BV Genzyme Flanders BV BiotechnologyHealth Technology Develops and manufactures biotherapeutic products	Health Technology
Lonza Verviers Lonza Verviers Chemicals: SpecialtyProcess Industries Manufactures industrial organic chemicals	Process Industries
BioWin ASBL BioWin ASBL Miscellaneous Commercial ServicesCommercial Services Provides support for research and development of biomarkers	Commercial Services
Catalent Gosselies NV Catalent Gosselies NV BiotechnologyHealth Technology Provides cell therapy manufacturing services	Health Technology
Cell Matters SA Cell Matters SA BiotechnologyHealth Technology Engages in cryo-processing and cryopreservation solutions	Health Technology
Dendrogenix SA Dendrogenix SA Pharmaceuticals: MajorHealth Technology Develops molecules and dendrogenins to treat hormone-dependent breast cancer	Health Technology